Quetiapine Fumarate Tablet, Extended Release
Product Images NDC 16729-109

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 16729-109). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quetiapine Fumarate Tablet, Extended Release 400 mg 60 Tablets Bottle (Quetiapine 150mg 60 Label)

FDA Label Image

Quetiapine Fumarate Tablet, Extended Release 400 mg 60 Tablets Bottle (Quetiapine 200mg 60 Label)

Each tablet contains 230 mg of Quetiapine Fumarate, the USP equivalent of Custapine 200 mg. The recommended storage temperature is between 20°-25°C. It is advised to keep it out of reach of children. This medication is to be taken orally and is available in a pack size of 80 tablets. Proper caution should be taken while dispensing this medicine. The dosage and usage instructions are not clear from the provided text.*

FDA Label Image

Quetiapine Fumarate Tablet, Extended Release 400 mg 60 Tablets Bottle (Quetiapine 300mg 60 Label)

This is a medication label for Quetiapine Extended-release Tablets USP with a dosage of 345mg, for use once daily. The medication should be stored at 20-25°C and should not be chewed or crushed. A warning to keep the medication away from children is also included. The label provides information about manufacturing, NDC number, and prescribing information. A medication guide is also enclosed for patients.*

FDA Label Image

Quetiapine Fumarate Tablet, Extended Release 400 mg 60 Tablets Bottle (Quetiapine 400mg 60 Label)

This is a medication called Quetiapine, which comes in the form of extended-release tablets. Each tablet contains 461 mg of Uetipine Fumarate, which is equivalent to 400 mg of Custiapine USP. The tablets should be stored at a temperature between 20-25°C (68-77°F) and only taken orally once daily. The accompanying prescribing information warns to keep the medication out of the reach of children, and medication guides are available for patients. The manufacturer is Accord Healthars Inc. from Durham, NC, and the tablets are manufactured by Intas Pharmaceuticals in Ahmedabad, India. The lot and expiration date can be overcoded on the area provided.*

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Quetiapine Figure 1)

FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Quetiapine Figure 2)

FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Quetiapine Figure 3)

This appears to be a graph showing the Proportion of Patients with Relapse over time, with two different curves labeled "ates VAL" and "PLac LwAL". However, without any additional context or information, it is difficult to provide a more detailed description or interpretation of the data.*

FDA Label Image

Structural Formula (Quetiapine Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.